Pharmaceutical R&D (Fargem)

• Consists of a team experienced in generic pharmaceutical research and development.
• Project-based works are carried out in Fargem Pharmaceutical formulation department in line with customer requests.
• The pharmaceutical formulation department has sufficient knowledge and experience in the development of solid, semi-solid, liquid, sterile, and non-sterile formulations.
• Fargem Formulation department has experience in development of conventional dosage forms, modified release systems, delayed-release, orally disintegrating tablets formulations, flash tablet formulations, micropellet formulations, and effervescent formulations.

• Fargem Formulation department continues its works on the development of new medicine release systems.
• Fargem Formulation department takes part in the pilot and scale-up manufacturing processes of the formulations it develops and helps in the commercial manufacturing process validations for the developed formulations
• Fargem Formulation department, with its experienced team and sufficient technical equipment, provides services for ensuring economical solutions for developing generic pharmaceutical formulations, new release systems, and manufacturing problems.
• Fargem Formulation department helps to prepare the required documents during the authorization processes of the formulations it developed.